Glucocorticoids regulate the expression of the human osteoblastic endothelin A receptor gene

Journal of Experimental Medicine

Volumn 188, Issue 9, 1998, Pages 1563-1573

  Börcsök, Irma ^a   Schairer, Hans U ^a   Sommer, Ulrike ^a   Wakley, Glenn K ^b   Schneider, Ulrich ^a   Geiger, Florian ^a   Niethard, Fritz U ^a   Ziegler, Reinhard ^a   Kasperk, Christian H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Bone; Endothelin 1; Endothelin A receptor; Glucocorticoids; Osteoblasts

Indexed keywords

DEFLAZACORT; DEXAMETHASONE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; GLUCOCORTICOID; IODINE 125; MIFEPRISTONE; PREDNISOLONE;

ARTICLE; BONE GROWTH; BONE METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; REPORTER GENE;

ADULT; AGED; BASE SEQUENCE; CELL DIVISION; DEXAMETHASONE; DNA; ENDOTHELIN-1; GENE EXPRESSION REGULATION; GENES, REPORTER; GLUCOCORTICOIDS; HORMONE ANTAGONISTS; HUMANS; KINETICS; MIDDLE AGED; MIFEPRISTONE; MOLECULAR SEQUENCE DATA; OSTEOBLASTS; PREDNISOLONE; PREGNENEDIONES; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; RNA, MESSENGER; TRANSFECTION;

EID: 0032476686     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.9.1563     Document Type: Article

References (41)

1. Jee, W.S.S. 1983. The skeletal tissues. In Histology, Cell and Tissue Biology. L. Weiss, editor. Elsevier Science Inc., New York. 200-255.
2. Vogt, M.T., J.A. Cauley, L.H. Kuller, and M.C. Nevitt. 1997. Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures. J. Bone Miner. Res. 12:283-288.
3. Mankin, H.J. 1992. Nontraumatic necrosis of bone (osteonecrosis). N. Engl. J. Med. 326:1473-1479.
4. Lukert, B.P., and L.G. Raisz. 1990. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann. Intern. Med. 112:352-364.
5. Canalis, E. 1983. Effect of glucocorticoids on type I collagen, alkaline phosphatase activity and deoxyribonucleic acid content in cultured rat calvariae. Endocrinology. 112:931-939.
6. Kanse, S.M., K. Takahashi, J.B. Warren, M. Ghatei, and S.R. Bloom. 1991. Glucocorticoids induce endothelin release from vascular smooth muscle cells but not endothelial cells. Eur. J. Pharmacol. 199:99-101.
7. Takahashi, K., K. Suda, H.-C. Lam, M.A. Ghatei, and S.R. Bloom. 1991. Endothelin-like immunoreactivity in rat models of diabetes mellitus. J. Endocrinol. 130:124-127.
8. Krum, H., R.J. Viskoper, Y. Lacourciere, M. Budde, and V. Charlon. 1998. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. N. Engl. J. Med. 338:784-790.
9. Coessens, B.C., V.M. Miller, and M.B. Wood. 1996. Endothelin induces vasoconstriction in the bone vasculature in vitro: an effect mediated by a single receptor population. J. Orthop. Res. 14:611-617.
10. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomombe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:411-415.
11. Kasperk, C.H., I. Börcsök, H.U. Schairer, U. Schneider, P.P. Nawroth, F.U. Niethard, and R. Ziegler. 1997. Endothelin-1 is a potent regulator of human bone cell metabolism in vitro. Calcif. Tissue Int. 60:368-374.
12. Robey, P.G., and J.D. Termine. 1985. Human bone cells in vitro. Calcif. Tissue Int. 37:453-460.
13. Kasperk, C.H., J.E. Wergedal, D.D. Strong, J.R. Farley, K. Wangerin, H. Gropp, R. Ziegler, and D.J. Baylink. 1995. Human bone cell phenotypes differ depending on their skeletal site of origin. J. Clin. Endocrinol. Metab. 80:2511-2517.
14. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
15. Scatchard, G. 1949. The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci. 51:660-672.
16. Luzzani, F., and A. Glässer. 1981. Differential binding in vitro to glucocorticoid receptors of deflazacort and prednisolone. Eur. J. Pharmacol. 76:427-430.
17. Canalis, E. 1996. Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J. Clin. Endocrinol. Metab. 81:3441-3447.
18. Rubin, J., D.M. Biskobing, L. Jadhav, D. Fan, M.S. Nanes, S. Perkins, and X. Fan. 1998. Dexamethasone promotes expression of membrane-bound macrophage colony-stimulating factor in murine osteoblast-like cells. Endocrinology. 139: 1006-1012.
19. Kaji, H., T. Sugimoto, M. Kanatani, K. Nishiyama, and K. Chihara. 1997. Dexamethasone stimulates osteoclast-like cell formation by directly acting on hemopoietic blast cells and enhances osteoclast-like cell formation stimulated by parathyroid hormone and prostaglandin E2. J. Bone Miner. Res. 12: 734-741.
20. Dempster, D.W. 1989. Bone histomorphometry in glucocorticoid-induced osteoporosis. J. Bone Miner. Res. 4:137-141.
21. Kasperk, C.H., U. Schneider, U. Sommer, F. Niethard, and R. Ziegler. 1995. Differential effects of glucocorticoids on human osteoblastic cell metabolism in vitro. Calcif. Tissue Int. 57:120-126.
22. Jonsson, K.B., A. Frost, R. Larsson, S. Ljunghall, and O. Ljunggren. 1997. A new fluorometric assay for determination of osteoblastic proliferation: effects of glucocorticoids and insulin-like growth factor-1. Calcif. Tissue Int. 60:30-36.
23. Ishida, Y., I. Tertinegg, and J.N. Heersche. 1996. Progesterone and dexamethasone stimulate proliferation and differentiation of osteoprogenitors and progenitors for adipocytes and macrophages in cell populations derived from adult rat vertebrae. J. Bone Miner. Res. 11:921-930.
24. Hulley, P.A., F. Gordon, and F.S. Hough. 1998. Inhibition of mitogen-activated protein kinase activity and proliferation of an early osteoblast cell line (MBA 15.4) by dexamethasone: role of protein phosphatases. Endocrinology. 139:2423-2431.
25. Shalhoub, V., D. Conlon, and M. Tassinari. 1992. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes. J. Cell. Biochem. 50:425-440.
26. Kamalia, N., C.A.G. McCulloch, H.C. Tenenbaum, and H. Limenack. 1992. Dexamethasone recruitment of self-renewing osteoprogenitor cells in chick bone marrow stromal cell cultures. Blood. 79:320-326.
27. Boden, S.D., G. Hair, L. Titus, M. Racine, K. McCuaig, J.M. Wozney, and M.S. Nanes. 1997. Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6. Endocrinology. 138: 2820-2828.
28. Kanse, S.M., K. Takahashi, J.B. Warren, T. Perara, M. Porta, M.A. Ghatei, and S.R. Bloom. 1991. Production of endothelin by smooth muscle cells. J. Cardiovasc. Pharmacol. 17(Suppl. 7):S113-S116.
29. Simonson, M.S., and M.J. Dunn. 1990. The molecular mechanisms of cardiovascular and renal regulation by endothelin peptides. FASEB J. 4:2989-3000.
30. Tatrai, A., S. Foster, P. Lakatos, G. Shankar, and P.H. Stern. 1992. Endothelin-1 actions on resorption, collagen and non-collagen protein synthesis, and phosphatidylinositol turnover in bone organ cultures. Endocrinology. 131:603-607.
31. Lempert, U.G., D.D. Strong, S. Mohan, K. Demarest, and D.J. Baylink. 1992. Effect of progesterone on the mRNA levels of insulin-like growth factors, IGF-binding proteins and type I-and type II-IGF receptors in human osteoblastic cells. In Calcium Regulating Hormones and Bone Metabolism. Basic and Clinical Aspects. D.V. Cohen, C. Gennari, and A.H. Tashjian, Jr., editors. Excerpta Medica, Inc., New York. 239-243.
32. Yeh, Y.C., E.R. Burns, J. Yeh, and H.W. Yeh. 1991. Synergistic effects of endothelin-1 and transforming growth factor alpha or epidermal growth factor on DNA replication and G1 to S phase transition. Biosci. Rep. 11:171-180.
33. Delany, A.M., Y. Dong, and E. Canalis. 1994. Mechanisms of glucocorticoid action in bone cells. J. Cell. Biochem. 56: 295-302.
34. Hirano, T., K. Oka, H. Takeuchi, E. Sakurai, N. Matsuno, T. Tamaki, and M. Kozaki. 1994. Clinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation. Transplantation (Baltimore). 57:1341-1348.
35. Pagano, G., A. Bruno, P. Cavallo-Perin, L. Cesco, and B. Imbimbo. 1989. Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Prednisone, deflazacort, and betamethasone. Arch. Intern. Med. 149:1098-1101.
36. Reid, I.R., and S.W. Heap. 1990. Determinants of vertebral mineral density in patients receiving chronic glucocorticoid therapy. Arch. Intern. Med. 150:2545-2548.
37. Hansson, A., K. Hehenberger, and M. Thorén. 1996. Long-term treatment of Swiss 3T3 fibroblasts with dexamethasone attenuates MAP kinase activation induced by insulin-like growth factor-I (IGF-I). Cell Biochem. Funct. 14:121-129.
38. Maroder, M., A.R. Farina, A. Vacca, M.P. Felli, D. Meco, I. Screpanti, L. Frati, and A. Gulino. 1993. Cell-specific bifunctional role of jun oncogene family members on glucocorticoid receptor-dependent transcription. Mol. Endocrinol. 7:570-584.
39. Beato, M., J. Arnemann, G. Chalepakis, E. Slater, and T. Willmann. 1987. Gene regulation by steroid hormones. J. Steroid Biochem. 27:9-14.
40. Dong, Y., L. Poellinger, J.-A. Gustafsson, and S. Okret. 1988. Regulation of glucocorticoid receptor expression: evidence for transcriptional and posttranslational mechanisms. Mol. Endocrinol. 2:1256-1263.
41. Hosoda, K., K. Nakao, N. Tamura, H. Arai, Y. Ogawa, S. Suga, S. Nakanishi, and H. Imura. 1992. Organization, structure, chromosomal assignment and expression of the gene encoding the human endothelin-A receptor. J. Biol. Chem. 267: 18797-18804.